Faculty

Back to Index
Jeffrey A Kahn, MD
Associate Professor of Clinical Medicine
Medicine
HCC 322U Health Sciences Campus Los Angeles
+1 323 442 5908

Overview

Dr. Kahn received fellowship training in gastroenterology and transplant hepatology from the Keck School of Medicine and Cedars-Sinai Medical Center. He is board certified in internal medicine, gastroenterology and transplant hepatology.

Dr. Kahn’s primary research interests are in liver transplantation, hepatocellular carcinoma and viral hepatitis. He has written and co-authored several abstracts and peer-reviewed articles on various topics such as chronic hepatitis C and liver transplantation. He is also a distinguished lecturer.

Awards

Alpha Omega Alpha

Publications

Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-acting Antiviral Agents for Recurrent Infection After Liver Transplantation. Gastroenterology. 2016 Nov 9. View in: PubMed

Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation. Transplant Direct. 2015 Jul; 1(6):e21. View in: PubMed

Imaging Appearance in Acute Liver Failure: Correlation with Clinical and Pathology Findings. Dig Dis Sci. 2014 Apr 2. View in: PubMed

Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology. 2010 Jun; 138(7):2321-31, 2331. e1-2. View in: PubMed

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial. Hepatology. 2006 Dec; 44(6):1675-84. View in: PubMed

Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial. Am J Gastroenterol. 2006 May; 101(5):983-92. View in: PubMed

A comparison of sirolimus vs. calcineurin inhibitor-based immunosuppressive therapies in liver transplantation. Aliment Pharmacol Ther. 2006 Feb 15; 23(4):513-20. View in: PubMed

Live donor liver transplantation without blood products: strategies developed for Jehovah's Witnesses offer broad application. Ann Surg. 2004 Aug; 240(2):350-7. View in: PubMed

Powered bySC CTSI